Retatrutide (LY3437943), marketed here as Reta-Solution, is an investigational multi-receptor peptide agonist that targets the receptors for GIP, GLP-1 and glucagon, and is used in experimental models of obesity, glycemic control and metabolic regulation
If the White House succeeds, the gray market may shrink but the unmet need wont
Finley says her physician told her a prior authorization was on file, but when she tried to refill her prescription, the pharmacist told her that Zepbound was denied
These support sustained weight management and can reduce long-term risk for type 2 diabetes
Danuglipron Danuglipron is an oral GLP-1RA developed by Pfizer
The synergy between these three systems creates effects greater than any single pathway could achieve alone